Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Cardiovascular disease prevalence and insulin resistance in the Kyushu-Okinawa Population Study and the Framingham Offspring Study.

Ikezaki H, Ai M, Schaefer EJ, Otokozawa S, Asztalos BF, Nakajima K, Zhou Y, Liu CT, Jacques PF, Cupples LA, Furusyo N.

J Clin Lipidol. 2017 Mar - Apr;11(2):348-356. doi: 10.1016/j.jacl.2017.01.014. Epub 2017 Feb 3.

PMID:
28502490
2.

Ethnic Differences in Glucose Homeostasis Markers between the Kyushu-Okinawa Population Study and the Framingham Offspring Study.

Ikezaki H, Ai M, Schaefer EJ, Otokozawa S, Asztalos BF, Nakajima K, Zhou Y, Liu CT, Jacques PF, Cupples LA, Furusyo N.

Sci Rep. 2016 Nov 10;6:36725. doi: 10.1038/srep36725.

3.

Associations of Serum Isoflavone, Adiponectin and Insulin Levels with Risk for Epithelial Ovarian Cancer: Results of a Case-control Study.

Otokozawa S, Tanaka R, Akasaka H, Ito E, Asakura S, Ohnishi H, Saito S, Miura T, Saito T, Mori M.

Asian Pac J Cancer Prev. 2015;16(12):4987-91.

4.

Relation of serum adiponectin levels and obesity with breast cancer: a Japanese case-control study.

Minatoya M, Kutomi G, Shima H, Asakura S, Otokozawa S, Ohnishi H, Akasaka H, Miura T, Mori M, Hirata K.

Asian Pac J Cancer Prev. 2014;15(19):8325-30.

5.

Lymph node shape in computed tomography imaging as a predictor for axillary lymph node metastasis in patients with breast cancer.

Kutomi G, Ohmura T, Satomi F, Takamaru T, Shima H, Suzuki Y, Otokozawa S, Zembutsu H, Mori M, Hirata K.

Exp Ther Med. 2014 Aug;8(2):681-685. Epub 2014 Jun 16.

6.

Relationship of serum isoflavone, insulin and adiponectin levels with breast cancer risk.

Minatoya M, Kutomi G, Asakura S, Otokozawa S, Sugiyama Y, Ohnishi H, Akasaka H, Miura T, Mori M, Hirata K.

Breast Cancer. 2015 Sep;22(5):452-61. doi: 10.1007/s12282-013-0502-2. Epub 2013 Oct 29.

PMID:
24166746
7.

Equol, adiponectin, insulin levels and risk of breast cancer.

Minatoya M, Kutomi G, Asakura S, Otokozawa S, Sugiyama Y, Nagata Y, Mori M, Hirata K.

Asian Pac J Cancer Prev. 2013;14(4):2191-9. Review.

8.

Plasma proprotein convertase subtilisin kexin type 9 levels are related to markers of cholesterol synthesis in familial combined hyperlipidemia.

Brouwers MC, Konrad RJ, van Himbergen TM, Isaacs A, Otokozawa S, Troutt JS, Schaefer EJ, van Greevenbroek MM, Stalenhoef AF, de Graaf J.

Nutr Metab Cardiovasc Dis. 2013 Nov;23(11):1115-21. doi: 10.1016/j.numecd.2012.11.008. Epub 2013 Jan 18.

PMID:
23333725
9.

[Cancer prevention].

Mori M, Asakura S, Otokozawa S, Minatoya M.

Nihon Rinsho. 2012 Jun;70 Suppl 4:10-6. Japanese. No abstract available.

PMID:
23156211
10.

Plasma glycated albumin level and atherosclerosis: results from the Kyushu and Okinawa Population Study (KOPS).

Furusyo N, Koga T, Ai M, Otokozawa S, Kohzuma T, Ikezaki H, Schaefer EJ, Hayashi J.

Int J Cardiol. 2013 Sep 1;167(5):2066-72. doi: 10.1016/j.ijcard.2012.05.045. Epub 2012 May 31.

PMID:
22658569
11.

Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the Framingham Heart Study.

van Himbergen TM, Beiser AS, Ai M, Seshadri S, Otokozawa S, Au R, Thongtang N, Wolf PA, Schaefer EJ.

Arch Neurol. 2012 May;69(5):594-600.

12.

Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese population study: results from the Kyushu and Okinawa Population Study (KOPS).

Furusyo N, Koga T, Ai M, Otokozawa S, Kohzuma T, Ikezaki H, Schaefer EJ, Hayashi J.

Diabetologia. 2011 Dec;54(12):3028-36. doi: 10.1007/s00125-011-2310-6. Epub 2011 Sep 27.

PMID:
21947435
13.

Adiponectin: an independent risk factor for coronary heart disease in men in the Framingham offspring Study.

Ai M, Otokozawa S, Asztalos BF, White CC, Cupples LA, Nakajima K, Lamon-Fava S, Wilson PW, Matsuzawa Y, Schaefer EJ.

Atherosclerosis. 2011 Aug;217(2):543-8. doi: 10.1016/j.atherosclerosis.2011.05.035. Epub 2011 Jun 12.

14.

Limitations of direct methods and the reference method for measuring HDL and LDL cholesterol.

Schaefer EJ, Otokozawa S, Ai M.

Clin Chem. 2011 Jul;57(7):1081-3; author reply 1083. doi: 10.1373/clinchem.2010.159483. Epub 2011 Mar 28. No abstract available.

15.

Effects of maximal atorvastatin and rosuvastatin treatment on markers of glucose homeostasis and inflammation.

Thongtang N, Ai M, Otokozawa S, Himbergen TV, Asztalos BF, Nakajima K, Stein E, Jones PH, Schaefer EJ.

Am J Cardiol. 2011 Feb 1;107(3):387-92. doi: 10.1016/j.amjcard.2010.09.031.

16.

Direct assessment of plasma low density lipoprotein and high density lipoprotein cholesterol levels and coronary heart disease: results from the Framingham Offspring Study.

Otokozawa S, Ai M, Asztalos BF, White CC, Demissie-Banjaw S, Cupples LA, Nakajima K, Wilson PW, Schaefer EJ.

Atherosclerosis. 2010 Nov;213(1):251-5. doi: 10.1016/j.atherosclerosis.2010.02.041. Epub 2010 Mar 9.

17.

Association of angiopoietin-like protein 3 with hepatic triglyceride lipase and lipoprotein lipase activities in human plasma.

Nakajima K, Kobayashi J, Mabuchi H, Nakano T, Tokita Y, Nagamine T, Imamura S, Ai M, Otokozawa S, Schaefer EF.

Ann Clin Biochem. 2010 Sep;47(Pt 5):423-31. doi: 10.1258/acb.2010.009307. Epub 2010 Jul 1.

PMID:
20595410
18.

Small dense LDL cholesterol and coronary heart disease: results from the Framingham Offspring Study.

Ai M, Otokozawa S, Asztalos BF, Ito Y, Nakajima K, White CC, Cupples LA, Wilson PW, Schaefer EJ.

Clin Chem. 2010 Jun;56(6):967-76. doi: 10.1373/clinchem.2009.137489. Epub 2010 Apr 29.

19.

Altering dietary lysine:arginine ratio has little effect on cardiovascular risk factors and vascular reactivity in moderately hypercholesterolemic adults.

Vega-López S, Matthan NR, Ausman LM, Harding SV, Rideout TC, Ai M, Otokozawa S, Freed A, Kuvin JT, Jones PJ, Schaefer EJ, Lichtenstein AH.

Atherosclerosis. 2010 Jun;210(2):555-62. doi: 10.1016/j.atherosclerosis.2009.12.002. Epub 2009 Dec 5.

20.

Familial combined hyperlipidemia is associated with alterations in the cholesterol synthesis pathway.

van Himbergen TM, Otokozawa S, Matthan NR, Schaefer EJ, Buchsbaum A, Ai M, van Tits LJ, de Graaf J, Stalenhoef AF.

Arterioscler Thromb Vasc Biol. 2010 Jan;30(1):113-20. doi: 10.1161/ATVBAHA.109.196550. Epub 2009 Oct 15.

21.

Fasting and postprandial apolipoprotein B-48 levels in healthy, obese, and hyperlipidemic subjects.

Otokozawa S, Ai M, Diffenderfer MR, Asztalos BF, Tanaka A, Lamon-Fava S, Schaefer EJ.

Metabolism. 2009 Nov;58(11):1536-42. doi: 10.1016/j.metabol.2009.04.040. Epub 2009 Jul 9.

22.

Glycated albumin and direct low density lipoprotein cholesterol levels in type 2 diabetes mellitus.

Ai M, Otokozawa S, Schaefer EJ, Asztalos BF, Nakajima K, Shrader P, Kathiresan S, Meigs JB, Williams G, Nathan DM.

Clin Chim Acta. 2009 Aug;406(1-2):71-4. doi: 10.1016/j.cca.2009.05.015. Epub 2009 May 22.

23.

Substitution of vegetable oil for a partially-hydrogenated fat favorably alters cardiovascular disease risk factors in moderately hypercholesterolemic postmenopausal women.

Vega-López S, Matthan NR, Ausman LM, Ai M, Otokozawa S, Schaefer EJ, Lichtenstein AH.

Atherosclerosis. 2009 Nov;207(1):208-12. doi: 10.1016/j.atherosclerosis.2009.03.039. Epub 2009 Apr 5.

24.

Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans.

Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, Graham JL, Hatcher B, Cox CL, Dyachenko A, Zhang W, McGahan JP, Seibert A, Krauss RM, Chiu S, Schaefer EJ, Ai M, Otokozawa S, Nakajima K, Nakano T, Beysen C, Hellerstein MK, Berglund L, Havel PJ.

J Clin Invest. 2009 May;119(5):1322-34. doi: 10.1172/JCI37385. Epub 2009 Apr 20.

25.

Effects of intensive atorvastatin and rosuvastatin treatment on apolipoprotein B-48 and remnant lipoprotein cholesterol levels.

Otokozawa S, Ai M, Van Himbergen T, Asztalos BF, Tanaka A, Stein EA, Jones PH, Schaefer EJ.

Atherosclerosis. 2009 Jul;205(1):197-201. doi: 10.1016/j.atherosclerosis.2008.11.001. Epub 2008 Nov 12.

26.

Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers.

van Himbergen TM, Matthan NR, Resteghini NA, Otokozawa S, Ai M, Stein EA, Jones PH, Schaefer EJ.

J Lipid Res. 2009 Apr;50(4):730-9. doi: 10.1194/jlr.P800042-JLR200. Epub 2008 Nov 30.

27.

Diversity of staphylocoagulase and identification of novel variants of staphylocoagulase gene in Staphylococcus aureus.

Kinoshita M, Kobayashi N, Nagashima S, Ishino M, Otokozawa S, Mise K, Sumi A, Tsutsumi H, Uehara N, Watanabe N, Endo M.

Microbiol Immunol. 2008 Jul;52(7):334-48. doi: 10.1111/j.1348-0421.2008.00045.x.

28.

Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and ApoB-containing lipoproteins.

Lamon-Fava S, Diffenderfer MR, Barrett PH, Buchsbaum A, Nyaku M, Horvath KV, Asztalos BF, Otokozawa S, Ai M, Matthan NR, Lichtenstein AH, Dolnikowski GG, Schaefer EJ.

Arterioscler Thromb Vasc Biol. 2008 Sep;28(9):1672-8. doi: 10.1161/ATVBAHA.108.164541. Epub 2008 Jun 19.

29.

Effects of maximal doses of atorvastatin versus rosuvastatin on small dense low-density lipoprotein cholesterol levels.

Ai M, Otokozawa S, Asztalos BF, Nakajima K, Stein E, Jones PH, Schaefer EJ.

Am J Cardiol. 2008 Feb 1;101(3):315-8. doi: 10.1016/j.amjcard.2007.08.035. Epub 2007 Dec 20.

PMID:
18237592
30.

Endogenous reactive oxygen species is an important mediator of miconazole antifungal effect.

Kobayashi D, Kondo K, Uehara N, Otokozawa S, Tsuji N, Yagihashi A, Watanabe N.

Antimicrob Agents Chemother. 2002 Oct;46(10):3113-7.

Supplemental Content

Loading ...
Support Center